stockrowGrace Therapeutics, Inc. (GRCE) vs Hyperion DeFi, Inc. (HYPD)
- Grace Therapeutics, Inc. GRCE 1.86 +4.49%
- Hyperion DeFi, Inc. HYPD 2.52 −1.56%
Grace Therapeutics, Inc. and Hyperion DeFi, Inc. are both Biotechnology companies. Grace Therapeutics, Inc. and Hyperion DeFi, Inc. are of similar size ($39.8M and $37.5M). Hyperion DeFi, Inc. grew revenue faster over the last twelve months: 1,990.6% against 1,286.8%. Grace Therapeutics, Inc. has the higher net margin (0.00% vs −1,224.5%) and the lower return on invested capital (−43.4% vs 2.73%). Across the 17 metrics below, Hyperion DeFi, Inc. leads on 11 and Grace Therapeutics, Inc. on 6.
Valuation
Profitability
| Metric | GRCE | HYPD | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 78.35% | 68.51% |
| Operating margin | 0.00% | 314.32% | 0.00% |
| Net margin | 0.00% | (1,224.53%) | 0.00% |
| Free cash flow margin | 0.00% | (5,509.35%) | 0.00% |
| Return on equity | (36.19%) | (24.63%) | (51.96%) |
| Return on assets | (33.74%) | (20.32%) | (46.06%) |
| Return on invested capital | (43.36%) | 2.73% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack